Alerts will be sent to your verified email
Verify Email
AUROLAB
|
Auro Laboratories
|
Kimia Biosciences
|
Pharmaids Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.83 % | -335.15 % | -15.3 % |
|
5yr average Equity Multiplier
|
1.84 | 66.02 | 1.31 |
|
5yr Average Asset Turnover Ratio
|
0.8 | 1.14 | 0.18 |
|
5yr Avg Net Profit Margin
|
9.49 % | -0.67 % | -26.11 % |
|
Price to Book
|
3.21 | 12.26 | 2.72 |
|
P/E
|
132.85 | 14.78 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
80.24 Days | -33.97 Days | -124.59 Days |
|
Inventory Days
|
56.39 Days | 101.63 Days | 79.26 Days |
|
Days Receivable
|
214.37 Days | 98.68 Days | 54.5 Days |
|
Days Payable
|
115.48 Days | 171.28 Days | 383.86 Days |
|
5yr Average Interest Coverage Ratio
|
10.53 | 0.78 | -741.3 |
|
5yr Avg ROCE
|
16.02 % | 10.6 % | -21.3 % |
|
5yr Avg Operating Profit Margin
|
15.11 % | 3.89 % | -35.99 % |
|
5 yr average Debt to Equity
|
0.48 | 29.85 | 0.16 |
|
5yr CAGR Net Profit
|
-23.84 % | 13.51 % | n/a |
|
5yr Average Return on Assets
|
7.53 % | -0.69 % | -13.12 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.18 % | 74.94 % | 32.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.09 % | 0.0 | 16.45 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Auro Laboratories
|
Kimia Biosciences
|
Pharmaids Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|